Frazier taking new company creation angle with $617M fund

For its latest and largest venture fund, Frazier Healthcare Ventures aims to conduct more company creation around novel targets while continuing to focus on its core areas of investment.

The firm will soon begin investing Frazier Life Sciences X, its third fund dedicated solely to life sciences start-ups. The $617 million vehicle is nearly 50% larger than Frazier’s 2017-vintage $419 million Fund IX. Overall, the new fund is Frazier's twelfth; it began raising separate growth buyout and life sciences funds in 2015...